Superficial Parasternal Intercostal Plane Blocks (SPIB) With Buprenorphine, Magnesium, and Bupivacaine for Management of Pain in Coronary Artery Bypass Grafting
Open Access
- 1 November 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e30964
Abstract
Management of post-operative pain after cardiac surgery continues to be a challenge; inadequate management of pain can lead to increased morbidity, impaired physical function with potential delay in recovery, increased perioperative and chronic opioid consumption, increased cost of care, and a decreased quality of life. This study aimed to evaluate the effect of adding buprenorphine and magnesium to bupivacaine for superficial parasternal intercostal plane blocks (SPIB) on pain and opioid consumption in the first 24 hours after coronary artery bypass grafting (CABG). Patients undergoing CABG were divided into the following four groups: saline SPIB, SPIB with bupivacaine (BPVC), SPIB with bupivacaine and buprenorphine (BPVC+BPRN), and SPIB with bupivacaine, buprenorphine, and magnesium (BPVC+BPRN+MG). The primary outcomes were pain scores and opioid consumption after SPIB; the secondary outcomes were post-operative nausea and vomiting, time to extubation, and length of stay (LOS) in the intensive care unit and hospital. One hundred thirty-four eligible patients undergoing CABG were randomized to either the saline (n=27), BPVC (n=20), BPVC+BPRN (n=24), or BPVC+BPRN+MG (n=29) group. All of the intervention groups combined (BPVC, BPVC+BPRN, and BPVC+BPRN+MG) had decreased pain scores and decreased opioid consumption when compared to the saline group; although not statistically significant, visual analog scale (VAS) scores trended downward at most time points with BPVC versus saline, BPVC+BPRN versus BPVC, and BPVC+BPRN+MG versus BPVC+BPRN. There was no difference among the study groups in the incidence of post-operative nausea and/or vomiting (PONV), time to extubation, hospital LOS, and ICU LOS. In this prospective, double-blind, placebo-controlled trial, we found that SPIB with local anesthetic is effective at reducing VAS scores and opioid consumption after CABG. Further study is needed to determine whether the addition of adjuvants can further improve pain control and opioid consumption.Keywords
This publication has 31 references indexed in Scilit:
- Addition of buprenorphine to local anesthetic in adductor canal blocks after total knee arthroplasty improves postoperative pain relief: a randomized controlled trialJournal of Clinical Anesthesia, 2016
- Actions of Bupivacaine, a Widely Used Local Anesthetic, on NMDA Receptor ResponsesJournal of Neuroscience, 2015
- Multimodal Perineural Analgesia with Combined Bupivacaine-Clonidine-Buprenorphine-Dexamethasone: Safe In Vivo and Chemically Compatible in SolutionPain Medicine, 2015
- Epidural analgesia for cardiac surgeryCochrane Database of Systematic Reviews, 2013
- Spinal epidural hematoma related to an epidural catheter in a cardiac surgery patient -A case report-Korean Journal of Anesthesiology, 2011
- Parasternal Intercostal Block With Ropivacaine for Pain Management After Cardiac Surgery: A Double-Blind, Randomized, Controlled TrialJournal of Cardiothoracic and Vascular Anesthesia, 2007
- The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical CareAnesthesia & Analgesia, 2007
- Magnesium and the inflammatory response: Potential physiopathological implicationsArchives of Biochemistry and Biophysics, 2007
- Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesiaRegional Anesthesia & Pain Medicine, 2002
- Neuraxial Blockade and Hematoma in Cardiac SurgeryChest, 2000